Evaluating kidney fibrosis using advanced microscopy techniques
Rapid quantitative renal fibrosis evaluation with dual-mode microscopy
['FUNDING_R01'] · EMORY UNIVERSITY · NIH-11251498
This study is testing a new microscope to help doctors get a quicker and more accurate look at kidney fibrosis, which can lead to chronic kidney disease, so that patients can receive better diagnoses and care for their kidney health.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | EMORY UNIVERSITY (nih funded) |
| Locations | 1 site (ATLANTA, UNITED STATES) |
| Trial ID | NIH-11251498 on ClinicalTrials.gov |
What this research studies
This research focuses on improving the evaluation of kidney fibrosis, a condition that can lead to chronic kidney disease (CKD). By utilizing a new type of microscope called DUET, the study aims to provide a faster and more accurate assessment of collagen distribution in kidney tissues. This method seeks to eliminate the challenges associated with traditional histological techniques, which can be time-consuming and prone to variability. Patients will benefit from a more precise diagnosis, potentially leading to better management of kidney health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with chronic kidney disease or those at risk of developing kidney fibrosis.
Not a fit: Patients with acute kidney injury that does not progress to chronic conditions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to quicker and more accurate diagnoses of kidney fibrosis, improving treatment outcomes for patients with chronic kidney disease.
How similar studies have performed: Previous research has shown promise in using advanced imaging techniques for tissue evaluation, suggesting that this approach could be effective.
Where this research is happening
ATLANTA, UNITED STATES
- EMORY UNIVERSITY — ATLANTA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: FEREIDOUNI, FARZAD — EMORY UNIVERSITY
- Study coordinator: FEREIDOUNI, FARZAD
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.